Annotated Medicine and Device Lists


Asparaginase

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 AGENTES ANTINEOPLÁSICOS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.05 OTHER ANTINEOPLASTIC DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTINEOPLÁSICOS No observations
El Salvador - 2019 ANTINEOPLASICOS: Otros agentes antineoplasicos No observations
Haiti. National List of Essential Medicines 08.02 Cytotoxic and adjuvant drugs No observations

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
Bulbo.

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 10. ANTINEOPLASTIC AND RELATED AGENTS No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 18.01. FÁRMACOS CITOTÓXICOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 8.2.1 Cytotoxic medicines No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 8.2 Cytotoxics No observations
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Miscellaneous Agents No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 41. Antineoplásicos y agentes inmunomoduladores No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.01. CITOTOXICOS O ANTINEOPLASICOS No observations
Suriname. NGK-C-011 8.2 Cytotoxic Agents No observations

Information Resources: Asparaginase

Loading ...
Loading ...
Loading ...
No information available